The cost-effectiveness of drug-eluting stents: a systematic review.

ABSTRACT:

Background

Drug-eluting stents have been seen as an attractive alternative to bare-metal stents for percutaneous coronary interventions (PCIs) because of the decreased need for revascularization. However, comparative clinical trials have shown no difference in patient outcomes, and drug-eluting stents are considerably more expensive than their bare-metal counterparts. We conducted a systematic review of all published comparative cost-effectiveness analyses to identify the factors contributing to the heterogeneity of their conclusions.

Methods

We retrieved all articles published between Jan. 1, 2000, and July 31, 2006, in which the cost-effectiveness, from a third-party payer perspective, of drug-eluting stents was compared with that of bare-metal stents for PCI in unrestrict

SUBMITTER: Ligthart S 

PROVIDER: S-EPMC1764790 | biostudies-literature | 2007 Jan

REPOSITORIES: biostudies-literature